Paul Grint

Chief Medical Officer, Kalypsys

Prior to joining Kalypsys, Dr. Paul Grint served as senior vice president and chief medical officer of Zephyr Sciences. He held similar positions at Pfizer, IDEC Pharmaceuticals and Schering-Plough Research Institute (SPRI). In addition, he was Chairman of the Biotechnology Therapy Team and an Honorary Lecturer in the Department of Virology at St. Bartholomew's Hospital in London. Dr. Grint had held a number of positions of increasing responsibility at SPRI, including Executive Director of the clinical research data management re-engineering project, Senior Director, Distinguished Clinical Research Physician and Director of Clinical Research in the anti-infectives department. He received his medical degree at University of London, St. Bartholomew's Hospital Medical College, and is a Fellow of the Royal College of Pathologists.